Kane Biotech Inc. (KNE.V)

CAD 0.1

(0.0%)

Market Cap (In CAD)

13.75 Million

Revenue (In CAD)

148.98 Thousand

Net Income (In CAD)

-5.03 Million

Avg. Volume

140.16 Thousand

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.07-0.17
PE
-
EPS
-
Beta Value
0.52
ISIN
CA4838092084
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Marc Edwards
Employee Count
-
Website
https://kanebiotech.com
Ipo Date
2003-10-01
Details
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.